Literature DB >> 3726582

Avascular necrosis of bone: a manifestation of Cushing's disease.

K A Phillips, E P Nance, R M Rodriguez, J J Kaye.   

Abstract

Cushing's disease is endogenous hypercortisolism due to a pituitary adenoma. Although exogenous hypercortisolism is a well known cause of avascular necrosis and although there have been many reports of avascular necrosis associated with endogenous Cushing's syndrome, there has only been a single well documented case report associating avascular necrosis of bone with Cushing's disease. We report four new cases of avascular necrosis of bone in patients with well documented Cushing's disease.

Entities:  

Mesh:

Year:  1986        PMID: 3726582     DOI: 10.1097/00007611-198607000-00011

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  6 in total

1.  Crutches in Cushing's disease.

Authors:  M B Davies; V V Babu; I R Scott
Journal:  J R Soc Med       Date:  2001-07       Impact factor: 5.344

2.  Avascular necrosis of femoral heads post-adrenal surgery for Cushing's syndrome: a rare presentation.

Authors:  A Saeed; L Bannan
Journal:  Ir J Med Sci       Date:  2011-05-12       Impact factor: 1.568

3.  Avascular necrosis of the femoral head: An exceptional complication of cushing's disease.

Authors:  Nadia Belmahi; Saïd Boujraf; Maazou Mahamane Larwanou; Hanan El Ouahabi
Journal:  Ann Afr Med       Date:  2018 Oct-Dec

4.  Spontaneous bone infarction of the distal femur in a patient with Cushing's disease: a case report.

Authors:  Pepijn van Houten; Jacky de Rooy; Ingrid van der Geest; Romana Netea-Maier; Annenienke van de Ven
Journal:  Bone Rep       Date:  2021-02-18

5.  Avascular femoral necrosis as part of Cushing syndrome presentation: a case report.

Authors:  Daniela Salazar; César Esteves; Maria João Ferreira; Jorge Pedro; Tiago Pimenta; Raquel Portugal; David Carvalho
Journal:  J Med Case Rep       Date:  2021-05-26

Review 6.  Hidden hypercortisolism: a too frequently neglected clinical condition.

Authors:  L Giovanelli; C Aresta; V Favero; M Bonomi; B Cangiano; C Eller-Vainicher; G Grassi; V Morelli; F Pugliese; A Falchetti; L Gennari; A Scillitani; L Persani; I Chiodini
Journal:  J Endocrinol Invest       Date:  2021-01-04       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.